Answers are grounded in this paper and cite their sources.
We showed in our study that citrate provided significantly longer circuit lifetimes than heparin for continuous venovenous hemodialysis in children. Citrate was superior to heparin for the transfusion requirements. Citrate was feasible and safe in children and infants.
No takes yet. Share an insight, caveat, or question.
Zaoral et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: